Peptide regulation tracker
The rules around peptides change constantly. We track every major event from FDA, MHRA, EMA, and WADA so you know what's legal, where, and why.
- 2026-07-15🇺🇸 United States
FDA scheduled vote on BPC-157 Status (projected)
The FDA is expected to deliver a ruling on BPC-157 in mid-July 2026 following the HHS reclassification. Major implications for US-based research-chemical vendors and compounding pharmacies.
neutral - 2026-03-01🇪🇺 European Union
Peptide Sciences EU shuts down
The EU operation of Peptide Sciences closed in March 2026, creating a supply gap filled by Slovak 7-parameter-tested suppliers and Cyprus-registered Toptimum Ltd. Worth re-checking vendor selection for EU shipping.
negative - 2026-02-15🇺🇸 United States
RFK Jr / HHS restores 14 peptides to legal compounding
Health Secretary Robert F. Kennedy Jr announced that approximately 14 previously restricted peptides would return to legal compounding status in the US, creating a surge of consumer interest and media coverage. Key compounds affected include BPC-157, TB-500, and several GH secretagogues.
positive - 2026-01-15🇺🇸 United States
Eli Lilly submits orforglipron FDA application
Eli Lilly submitted its New Drug Application for orforglipron, the first orally bioavailable GLP-1 agonist to reach late-stage approval. Approval expected late 2026 / early 2027. Sets up a direct confrontation with Ozempic and Wegovy.
positive - 2025-12-01🇬🇧 United Kingdom
Mounjaro available on NHS for obesity
Tirzepatide (Mounjaro) became available through NHS specialist services for adults with BMI ≥35 + one weight-related comorbidity. Still limited supply; private route remains fastest.
positive - 2025-06-01🇬🇧 United Kingdom
Wegovy expanded under NHS weight-management service
MHRA and NHS expanded access to Wegovy (semaglutide) through specialist weight-management services in England. Private prescription still the faster route for eligible patients.
positive - 2025-06-01🌍 Global
Gray-market peptide imports from China hit $328M
Aggregate imports of peptide material from Chinese manufacturers reached $328M in 2025. Partially driven by 2023 FDA restrictions pushing demand underground, per multiple trade press sources.
neutral - 2025-01-01🏅 WADA (sport)
BPC-157 added to WADA prohibited list
The World Anti-Doping Agency added BPC-157 to its prohibited list at all times, matching its existing position on TB-500 and all GH secretagogues. Competitive athletes subject to WADA cannot use these compounds.
negative